GSK plc reports results for the quarter ended June 30 - Earnings Summary
GSK plc reports results for the quarter ended June 30 - Earnings Summary
GSK plc GSK.L reported quarterly adjusted earnings of 51 pence per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 47 pence. The mean expectation of seven analysts for the quarter was for earnings of 46 pence per share. Wall Street expected results to range from 40 pence to 48 pence per share.
Revenue rose 5.3% to £8.41 billion from a year ago; analysts expected £8.24 billion.
GSK plc's reported EPS for the quarter was 11 pence.
The company reported quarterly net income of £435 million.
GSK plc shares had fallen by 1.0% this quarter and gained 7.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2.7% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy," 14 "hold" and 3 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for GSK plc is GBp2,060.00, about 4.8% above its last closing price of GBp1,961.00
This summary was machine generated from LSEG data July 28 at 01:14 p.m. UTC. All figures in pounds unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.46 | 0.51 | Beat |
Mar. 31 2026 | 0.43 | 0.47 | Beat |
Dec. 31 2025 | 0.23 | 0.26 | Beat |
Sep. 30 2025 | 0.47 | 0.55 | Beat |